Executive function, but not memory, associates with incident coronary heart disease and stroke

Neurology

Volumn 85, Issue 9, 2015, Pages 783-789

  Rostamian, Somayeh ^a   Van Buchem, Mark A ^a   Westendorp, Rudi G J ^a,b   Jukema, J Wouter ^a   Mooijaart, Simon P ^a   Sabayan, Behnam ^a   De Craen, Anton J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PRAVASTATIN;

AGED; ARTICLE; ASSESSMENT OF HUMANS; CEREBROVASCULAR ACCIDENT; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LETTER DIGIT SUBSTITUTION TEST; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PICTURE LEARNING TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELECTIVE ATTENTION; STROOP TEST; CORONARY DISEASE; LONGITUDINAL STUDY; MEMORY; MENTAL HEALTH; MULTICENTER STUDY (TOPIC); MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CORONARY DISEASE; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MEMORY; MENTAL STATUS SCHEDULE; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 84946747392     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001895     Document Type: Article

References (33)

1. Unverzagt FW, McClure LA, Wadley VG, et al. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 2011;77:1729-1736.
2. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005;64:277-281.
3. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009;8:1006-1018.
4. Veglio F, Paglieri C, Rabbia F, Bisbocci D, Bergui M, Cerrato P. Hypertension and cerebrovascular damage. Atherosclerosis 2009;205:331-341.
5. Giorda CB, Avogaro A, Maggini M, et al. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 2007;38:1154-1160.
6. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989;298:789-794.
7. Okusaga O, Stewart MC, Butcher I, Deary I, Fowkes FG, Price JF. Smoking, hypercholesterolaemia and hypertension as risk factors for cognitive impairment in older adults. Age Ageing 2013;42:306-311.
8. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 2012;42:484-491.
9. Brunnstrom HR, Englund EM. Cause of death in patients with dementia disorders. Eur J Neurol 2009;16: 488-492.
10. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222.
11. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-151.
12. de Galan BE, Zoungas S, Chalmers J, et al. Cognitive function and risks of cardiovascular disease and hypogly-caemia in patients with type 2 diabetes: the action in diabetes and vascular disease: Preterax and Diamicron modified release controlled evaluation (ADVANCE) trial. Diabetologia 2009;52:2328-2336.
13. O'Donnell M, Teo K, Gao P, et al. Cognitive impairment and risk of cardiovascular events and mortality. Eur Heart J 2012;33:1777-1786.
14. Shepherd J, Blauw GJ, Murphy MB, et al. The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER): PROSPER Study Group: Prospective Study of Pravastatin in the Elderly at Risk. Am J Cardiol 1999; 84:1192-1197.
15. Houx PJ, Shepherd J, Blauw GJ, et al. Testing cognitive function in elderly populations: the PROSPER study: Prospective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry 2002;73:385-389.
16. Sabayan B, Gussekloo J, de Ruijter W, Westendorp RG, de Craen AJ. Framingham stroke risk score and cognitive impairment for predicting first-time stroke in the oldest old. Stroke 2013;44:1866-1871.
17. Weinstein G, Beiser AS, Decarli C, Au R, Wolf PA, Seshadri S. Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study. Stroke 2013;44:2787-2794.
18. Rostamian S, Mahinrad S, Stijnen T, Sabayan B, de Craen AJ. Cognitive impairment and risk of stroke: a systematic review and meta-analysis of prospective cohort studies. Stroke 2014;45:1342-1348.
19. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128: 2034-2041.
20. Hurford R, Charidimou A, Fox Z, Cipolotti L, Werring DJ. Domain-specific trends in cognitive impairment after acute ischaemic stroke. J Neurol 2013;260:237-241.
21. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:2672-2713.
22. Breteler MM, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ 1994;308: 1604-1608.
23. Roberts RO, Knopman DS, Geda YE, Cha RH, Roger VL, Petersen RC. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neu-robiol Aging 2010;31:1894-1902.
24. Alonso A, Jacobs DR Jr, Menotti A, et al. Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the seven countries study. J Neurol Sci 2009;280:79-83.
25. de Moraes SA, Szklo M, Tilling K, Sato R, Knopman D. Cognitive functioning as a predictor of ischemic stroke incidence. Epidemiology 2003;14:673-679.
26. Haratz S, Tanne D. Diabetes, hyperglycemia and the management of cerebrovascular disease. Curr Opin Neurol 2011;24:81-88.
27. Reitz C, Brickman AM, Luchsinger JA, Wu WE, Small SA, Tang MX. Frequency of subclinical heart disease in elderly persons with dementia. Am J Geriatr Cardiol 2007;16:183-188.
28. Whincup PH, Gilg JA, Emberson JR, et al. Passive smok ing and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ 2004;329: 200-205.
29. Hillbom M, Saloheimo P, Juvela S. Alcohol consumption, blood pressure, and the risk of stroke. Curr Hypertens Rep 2011;13:208-213.
30. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007; 6:611-619.
31. Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-1129.
32. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-2217.
33. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165:2644-2650.